Literature DB >> 8843306

Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes.

A Bauernfeind1, I Stemplinger, R Jungwirth, R Wilhelm, Y Chong.   

Abstract

A plasmidic beta-lactamase which hydrolyzed cephamycins was first detected and reported in 1989. At that time its description was restricted to phenotypic characteristics. We analyzed nucleotide sequence of its gene and explored it genetic relationship with other bla genes. The deduced amino acid sequence of the blaCMY-1 product was compared with those of other known plasmidic cephamycinases and of chromosomal AmpC beta-lactamases. The results indicate that the relationship of CMY-1 is closest to MOX-1 among the plasmidic cephamycinases and to AmpC of Pseudomonas aeruginosa among the chromosomal cephalosporinases. We conclude that the plasmidic cephamycinases described up to now may be classified into three families, as follows: CMY-1, MOX-1, and FOX-1 with AmpC of P. aeruginosa; CMY-2, BIL-1 and LAT-1 with AmpC of Citrobacter freundii; and MIR-1 with AmpC of Enterobacter cloacae. Plasmidic cephamycinases are now recognized as clinically relevant class C beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843306      PMCID: PMC163442     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Fast and sensitive multiple sequence alignments on a microcomputer.

Authors:  D G Higgins; P M Sharp
Journal:  Comput Appl Biosci       Date:  1989-04

2.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

3.  Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products.

Authors:  M Galleni; F Lindberg; S Normark; S Cole; N Honore; B Joris; J M Frere
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

4.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

5.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

6.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

Review 7.  Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.

Authors:  C C Sanders; W E Sanders
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

8.  ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.

Authors:  B Jaurin; T Grundström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene.

Authors:  F Lindberg; S Normark
Journal:  Eur J Biochem       Date:  1986-05-02
View more
  44 in total

1.  A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii.

Authors:  C Verdet; G Arlet; G Barnaud; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; H Sahly; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

4.  Nucleotide sequence of the chromosomal ampC gene of Enterobacter aerogenes.

Authors:  K E Preston; C C Radomski; R A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

5.  BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors:  Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 6.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

7.  Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate.

Authors:  A M Queenan; S Jenkins; K Bush
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

8.  Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain.

Authors:  G Bou; A Oliver; M Ojeda; C Monzón; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

9.  Novel plasmid-encoded class C beta-lactamase (MOX-2) in Klebsiella pneumoniae from Greece.

Authors:  Laurent Raskine; Isabelle Borrel; Guilène Barnaud; Sophie Boyer; Béatrice Hanau-Berçot; Jérome Gravisse; Roger Labia; Guillaume Arlet; Marie-José Sanson-Le-Pors
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

10.  blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513.

Authors:  Sonia M Arduino; Paul H Roy; George A Jacoby; Betina E Orman; Silvia A Pineiro; Daniela Centron
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.